Oramed to Present at PIONEERS 2016, Presented by Joseph Gunnar

JERUSALEM, April 28, 2016
Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that the Company will participate in the upcoming PIONEERS 2016 conference, presented by Joseph Gunnar & Co. LLC, taking place on […]

Categories: Press Releases|Tags: |

Oramed Receives Patent Term Adjustment Extending the Term of Its U.S. Patent

Patent addresses platform technology for oral insulin capsule ORMD-0801

JERUSALEM, April 12, 2016 /PRNewswire/ —

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that the U.S. Patent and Trademark Office (PTO) has issued a […]

Categories: Press Releases|Tags: |

Oramed Completes Phase IIb Oral Insulin Study

Top-Line Data to be Released This Quarter

JERUSALEM, April 5, 2016
Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that all follow-up visits in the Company’s Phase IIb study of its oral insulin capsule, […]

Categories: Press Releases|Tags: |

Oramed Patent Granted in India for Oral Administration of Proteins

JERUSALEM, March 29, 2016
Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that the Company’s patent for its invention, titled “Methods and Compositions for Oral Administrations of Proteins” has been granted by the Indian Patent Office.
About Oramed Pharmaceuticals

Oramed Pharmaceuticals […]

Categories: Press Releases|Tags: |

Oramed to Present at the BIO CEO & Investor Conference

JERUSALEM, February 4, 2016
Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that the Company will participate in the upcoming 18th Annual BIO CEO & Investor Conference, taking place February 8-9, 2016 in […]

Categories: Press Releases|Tags: |

Oramed Pharmaceuticals’ Shareholder Letter

JERUSALEM, January 6, 2016 /PRNewswire/ —

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), today issued the following shareholder letter:

Dear Shareholders, 

2015 was a very significant year for us at Oramed setting the bar high for what we anticipate to be a momentous year ahead in 2016.

2015 Major Milestones […]

Categories: Press Releases|Tags: |

Oramed Announces Closing of Licensing and Investment Deal with HTIT for Oral Insulin Capsule in China

JERUSALEM, December 29, 2015 /PRNewswire/ —

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, today announced the closing of its previously-announced license and investment deal with Hefei Tianhui Incubation of Technologies Co. Ltd. (“HTIT”). Oramed has sold 1,155,367 restricted shares of […]

Categories: Press Releases|Tags: |

Oramed Signs up to $50 Million Licensing and Investment Agreements for Oral Insulin Capsule in China

Receiving up to $38,000,000 + royalties for licensing deal and $12,000,000 for equity investment at $10.39 per share

JERUSALEM, Nov. 30, 2015 /PRNewswire/ — Oramed Pharmaceuticals Inc. (NASDAQ: ORMP), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today it has […]

Categories: Press Releases|Tags: |

Oramed to Present at the Aegis Capital Growth Conference

JERUSALEM, October 1, 2015 /PRNewswire/ —

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that the Company will participate in the upcoming Aegis Growth Conference, taking place October 7-9, 2015 in Las Vegas. […]

Categories: Press Releases|Tags: |

Oramed Patent Allowed in the US for Oral Administration of Proteins

JERUSALEM, September 24, 2015 /PRNewswire/ —

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that the Company’s patent for its invention, titled “Methods and Compositions for Oral Administrations of Proteins” has been allowed by the United States Patent and […]

Categories: Press Releases|Tags: |